Doctors Prescribing Unapproved Weight-Loss Drug Amid Social Media Buzz

Executive Briefing

• Highlights physicians prescribing a weight-loss drug that has not received FDA approval
• Reveals social media virality is driving patient demand and accelerating off-label prescribing
• Raises safety concerns as the drug lacks full regulatory review and long-term data
• Shows some doctors are bypassing standard approval processes, citing urgency over caution